Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-07
1996-08-20
Martinell, James
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
435686, 5303887, 530397, 530835, A61K 3818, C12P 2102
Patent
active
055479332
ABSTRACT:
Disclosed are novel polypeptides possessing part or all of the primary structural conformation and one or more of the biological properties of mammalian erythropoietin ("EPO") which are characterized in preferred forms by being the product of procaryotic or eucaryotic host expression of an exogenous DNA sequence. Illustratively, genomic DNA, cDNA and manufactured DNA sequences coding for part or all of the sequence of amino acid residues of EPO or for analogs thereof are incorporated into autonomously replicating plasmid or viral vectors employed to transform or transfect suitable procaryotic or eucaryotic host cells such as bacteria, yeast or vertebrate cells in culture. Upon isolation from culture media or cellular lysates or fragments, products of expression of the DNA sequences display, e.g., the immunological properties and in vitro and in vivo biological activities of EPO of human or monkey species origins. Disclosed also are chemically synthesized polypeptides sharing the biochemical and immunological properties of EPO. Also disclosed are improved methods for the detection of specific single stranded polynucleotides in a heterologous cellular or viral sample prepared from, e.g., DNA present in a plasmid or viral-borne cDNA or genomic DNA "library".
REFERENCES:
patent: 3033753 (1962-05-01), White et al.
patent: 3865801 (1975-02-01), Chiba et al.
patent: 4237224 (1980-12-01), Cohen et al.
patent: 4254095 (1981-03-01), Fisher et al.
patent: 4264731 (1981-04-01), Shine
patent: 4273875 (1981-06-01), Manis
patent: 4293652 (1981-10-01), Cohen
patent: 4303650 (1981-12-01), Takezawa et al.
patent: 4338397 (1982-07-01), Gilbert et al.
patent: 4358535 (1982-11-01), Falkow et al.
patent: 4377513 (1983-03-01), Sugimoto et al.
patent: 4394443 (1983-07-01), Weissman et al.
patent: 4397840 (1933-08-01), Takezawa et al.
patent: 4399216 (1983-08-01), Axel et al.
patent: 4411994 (1983-10-01), Gilbert et al.
patent: 4442205 (1984-04-01), Hamer et al.
patent: 4465624 (1984-08-01), Chiba et al.
patent: 4467016 (1987-05-01), Lai et al.
patent: 4468464 (1984-08-01), Cohen et al.
patent: 4503151 (1985-03-01), Paddock
patent: 4558005 (1985-12-01), Goldwasser et al.
patent: 4558006 (1985-12-01), Egrie
patent: 4568488 (1986-02-01), Lee-Huang
patent: 4667016 (1987-05-01), Lai et al.
patent: 4677195 (1987-06-01), Hewick et al.
patent: 4695542 (1987-09-01), Yokata et al.
patent: 4703008 (1987-10-01), Lin
patent: 4710473 (1987-12-01), Morris
patent: 4757006 (1988-07-01), Toole et al.
Abraham et al., "Nucleotide Sequence of a Bovine Clone Encoding the Angiogenic Protein, Basic Fibroblast Growth Factor," Science, 233, 545-548 (Aug. 1, 1986) [F].
Adamson, "The Polycythemias: Diagnosis and Treatment," Hosp. Practice, 18(12), 49-57 (Dec. 1983) [A].
Aebi, "Sequence Requirements for Splicing of Higher Eukaryotic Nuclear Pre-mRNA," Cell, 47, 555-565 (Nov. 1986) [F].
Agarwal et al., "A General Method for Detection and Characterization of an mRNA using an Oligonuclotide Probe," J. Biol. Chem., 256, 1023-1028 (Jan. 25, 1981) [F].
Anderson et al., "Isolation of a genomic clone for bovine pancreatic trypsin inhibitor by using a unique-sequence synthetic DNA probe," P.N.A.S. (USA), 80, 6838-6842 (Nov. 1983) [A,F].
Baciu et al., "Erythropoietin Interaction with the Mature Red Cell Membrane," Ann. N.Y. Acad. Sci., 414, 66-72 (1983) [A].
Baron et al., "Antibodies against the Chemically Synthesized Genome-Linked Protein of Poliovirus React with Native Virus-Specific Proteins," Cell, 28, 395-404 (Feb. 1982) [A].
Beaucage et al., "Deoxynucleoside Phosphoramidites-A new Class of Key Intermediates for Deoxypolynucleotide Synthesis," Tetrahedron Letters, 22(20), 1859-1862 (1981) [A,F].
Benedum et al., "The primary structure of bovine chromogranin A: a representative of a class of acidic secretory proteins common to a variety of peptidergic cells," EMBO J. 5(7), 1495-1502 (1986) [F].
Bennetzen et al., "Codon Selections in Yeast," J. Biol. Chem., 257(6), 3026-3031 (Mar. 25, 1982) [A].
Bentley et al., "Human immunoglobulin variable region genes-DNA sequences of two V.sub.k genes and a pseudogene," Nature, 288, 730-733 (Dec. 1980) [F].
Benton et al., "Screening .lambda.gt Recombinant Clones by Hybridization to single Plaques in situ," Science, 196, 180-182 (Apr. 8, 1977) [F].
Berzofsky et al., "Topographic Antigenic Determinants Recognized by Monoclonal Antibodies to Sperm Whale Myoglobin," J. Biol. Chem. 257(6), 3189-3198 (Mar. 25, 1982) [F].
Berzofsky et al., "Properties of Monoclonal Antibodies Specific for Determinants of a Protein Antigen, Myoglobin," J. Biol. Chem. 255(23), 11188-11191 (Dec. 10, 1980) [F].
Betsholtz et al., "cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines," Nature 320, 695-699 (Apr. 24, 1986) [F].
Billat et al., "In Vitro and In Vivo Regulation of Hepatic Erythropoiesis by Erythropoietin and Glucocorticoids in the Rat Fetus," Exp. Hematol., 10(1), 133-140 (1982) [A].
Blattner et al., "Charon Phages: Safer Derivatives of Bacteriophage Lambda for DNA Cloning," Science, 196, 161-169 (Apr. 8, 1977) [A,F].
Bos et al., "Eukaryotic Expression of Cloned cDNA Coding for Influenza Viral Glycoproteins Using an SV40 Vector: Use of Recombinant DNA Mutants to Study Structure-Function Relationships.sup.1," Proc. Symp. Mol. Biol. Negat., Strand Viruses Meeting, pp. 125-130, Compans et al., eds., Acad. Press (1984) [B].
Bray et al., "Human cDNA clones for four species of G.alpha.-signal transduction protein," P.N.A.S. (USA), 83, 8893-8897 (Dec. 1986) [F].
Breslow et al., "Isolation and characterization of cDNA clones for human apolipoprotein A-I," P.N.A.S. (USA), 79, 6861-6865 (Nov. 1982) [A,D,E,F].
Broome et al., "Immunological screening method to detect specific translation products," P.N.A.S. (USA), 75(6), 2746-2749 (Jun. 1978) [A].
Canaani et al. "Regulated expression of human interferon .beta.1 gene after transduction into cultured mouse and rabbit cells," P.N.A.S. (USA), 79, 5166-5170 (Sep. 1982) [D].
Chan et al., "Construction and selection of recombinant plasmids containing full-length complementary DNAs corresponding to rat insulins I and II," P.N.A.S. (USA), 76(10), 5036-5040 (Oct. 1979) [F].
Chia et al., "The construction of cosmid libraries of eukaryotic DNA using the Homer series of vectors," Nucleic Acids Res. 10(8), 2503-2520 (1992) [F].
Chirgwin et al., "Isolation of Biologically Active Ribonucleic Acid from Sources Enriched in Ribonuclease," Biochemistry, 18(24), 5294-5299 (1979) [A,F].
Chisholm, "On the Trail of the Magic Bullet: Monoclonal antibodies promise perfectly targeted chemicals," High Technology, vol. 2(1), 57-63 (Jan. 1983) [A].
Chomczynski et al., "Alkaline Transfer of DNA to Plastic Membrane," Biochem. Biophys. Res. Commun., 122(1), 340-44 (1984) [A].
Choo et al., "Molecular cloning of the gene for human anti-haemophilic factor IX," Nature, 299, 178-180 (Sep. 9, 1982) [A,F].
Choppin et al., "Characterization of Erythropoietin Produced by IW32 Murine Erythroleukemia Cells," Blood, 64(2), 341-347 (Aug. 1984) [A,F].
Chou et al., "Prediction of Protein Conformation," Biochem., 13(2), 222-245 (1974) [A].
Chou et al., "Prediction of the Secondary Structure of Proteins from their Amino Acid Sequence," Advances in Enzymology, 47, 45-47 (1978) [A].
Chou et al., "Empirical Predictions of Protein Conformation," Ann. Rev. Biochem., 47, 251-76 (1978) [A].
Christman et al., "Amplification of expression of hepatitis B surface antigen in 3T3 cells cotransfected with a dominant-acting gene and cloned viral DNA," P.N.A.S. (USA), 79, 1815-1819 (Mar. 1982) [F].
Claus-Walker et al., "Spinal Cord Injury and Serum Erythropoietin," Arch. Phys. Med. Rehabil., 65, 370-374 (Jul. 1984) [A].
Colby et al., "Immunological Differentiation Between E. coli and CHO Cell-Derived Recombinant and Natural Human .beta.-Interferons.sup.1," J. Immunol., 133(6), 3091-3095 (1984) [B].
Collen et al., "Biological Properties of Human Tissue-Type Plasminogen Activator Obtained by Expression of Recombinant DNA," J. of Pharmacology and Exp. Therapeutics, 231
Kirin-Amgen Inc.
Martinell James
LandOfFree
Production of erythropoietin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Production of erythropoietin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Production of erythropoietin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2330783